Diadema Partners »

Pepgen shares owned by Diadema Partners

Quarter-by-quarter ownership of Pepgen (PEPG) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Pepgen

Tip: Access up to 7 years of quarterly data

All positions including Pepgen held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pepgen by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $267k 151k 1.77

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Pepgen

RA Capital Management
Commodore Capital
Viking Global Investors
Laurion Capital Management
Vivo Capital
Millennium Management
Vanguard Capital Management
AWM Investment Company
ADAR1 Capital Management
Woodline Partners
BlackRock
Kalehua Capital Management
Morgan Stanley
Susquehanna International
Ikarian Capital

View all funds holding Pepgen